Cholestech
Executive Summary
Eric McAllister, MD/PhD, on board as VP clinical affairs from Bristol-Myers Squibb, where he was most recently exec director of medical operations. Robert Baughman, PharmD/PhD, joins as director of preclinical development. He was previously group leader of R&D at Penederm and was formerly with Genentech.